Biosensor Analysis of Drug–Target Intera
✍
Robert Karlsson; Mari Kullman-Magnusson; Markku D. Hämäläinen; Annika Remaeus; K
📂
Article
📅
2000
🏛
Elsevier Science
🌐
English
⚖ 202 KB
The sensitivity of BIACORE technology is sufficient for detection and characterization of binding events involving low-molecular-weight compounds and their immobilized protein targets. The technology requires no labeling and provides information on the stability of the compound/target complex with a